Is it worthwhile adding glitazone therapy to insulin-treated Type 2 patients in poor glycaemic control? A prospective audit

被引：0
|
作者：
Levy, D. [1 ]
Liew, L. [1 ]
Barron, B. [1 ]
Manogaraan, B. [1 ]
Reilly, P. [1 ]
机构：
[1] Whipps Cross Univ Hosp, Dept Endocrinol & Diabet, London, England
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [21] Acarbose improves glycaemic control in patients with insulin - Treated type 2 diabetes.
    Simpson, H
    Robertson-Mackay, F
    Montegriffo, E
    Fox, C
    DIABETOLOGIA, 1999, 42 : A223 - A223
  • [22] Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
    Sandro Gentile
    Giuseppina Guarino
    Teresa Della Corte
    Giampiero Marino
    Alessandra Fusco
    Gerardo Corigliano
    Sara Colarusso
    Marco Piscopo
    Maria Rosaria Improta
    Marco Corigliano
    Emilia Martedi
    Domenica Oliva
    Viviana Russo
    Rosa Simonetti
    Ersilia Satta
    Carmine Romano
    Sebastiano Vaia
    Felice Strollo
    Diabetes Therapy, 2021, 12 : 107 - 119
  • [23] Progression of retinopathy in insulin-treated type 2 diabetic patients
    Henricsson, M
    Berntorp, K
    Fernlund, P
    Sundkvist, G
    DIABETES CARE, 2002, 25 (02) : 381 - 385
  • [24] Hypoglycemia in stable insulin-treated patients with type 2 diabetes
    Hoffman, RM
    Shah, JH
    Duckworth, WC
    Wendel, CS
    Murata, GH
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 148 - 148
  • [25] Inflammatory cytokines in insulin-treated patients with type 2 diabetes
    Mavridis, G.
    Souliou, E.
    Diza, E.
    Symeonidis, G.
    Pastore, F.
    Vassiliou, A. M.
    Karamitsos, D.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (07) : 471 - 476
  • [26] Troglitazone use in insulin-treated type 2 diabetic patients
    Buse, JB
    Gumbiner, B
    Mathias, NP
    Nelson, DM
    Faja, BW
    Whitcomb, RW
    DIABETES CARE, 1998, 21 (09) : 1455 - 1461
  • [27] Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
    Gentile, Sandro
    Guarino, Giuseppina
    Della Corte, Teresa
    Marino, Giampiero
    Fusco, Alessandra
    Corigliano, Gerardo
    Colarusso, Sara
    Piscopo, Marco
    Improta, Maria Rosaria
    Corigliano, Marco
    Martedi, Emilia
    Oliva, Domenica
    Russo, Viviana
    Simonetti, Rosa
    Satta, Ersilia
    Romano, Carmine
    Vaia, Sebastiano
    Strollo, Felice
    DIABETES THERAPY, 2021, 12 (01) : 107 - 119
  • [28] Low c-peptide is associated with high glycaemic variability and hypoglycaemia in insulin-treated patients with Type 2 diabetes
    Hope, S. V.
    Knight, B. A.
    Shields, B. M.
    Strain, W. D.
    Hattersley, A. T.
    Choudhary, P.
    Jones, A. G.
    DIABETIC MEDICINE, 2016, 33 : 18 - 18
  • [29] A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes
    Raskin, P
    Rendell, M
    Riddle, MC
    Dole, JF
    Freed, MI
    Rosenstock, J
    DIABETES CARE, 2001, 24 (07) : 1226 - 1232
  • [30] Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes
    Zib, Ivana
    Jacob, Aris N.
    Lingvay, Ildiko
    Salinas, Karin
    McGavock, Jonathan M.
    Raskin, Philip
    Szczepaniak, Lidia S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (05) : 230 - 236
12345